Prenetics Global Limited has announced a significant update to its capital allocation strategy as it shifts its focus entirely toward its rising consumer health brand, IM8. Effective December 4, 2025, the company will cease all Bitcoin purchasing activities and has received Board approval to halt any future acquisitions of Bitcoin. This strategic realignment is intended to capitalize on the impressive growth opportunities presented by IM8, which has rapidly established itself as the fastest-growing supplement brand in the industry.
According to projections, IM8 is expected to generate revenues of $180 to $200 million for fiscal year 2026. In just 11 months since its launch, IM8 surpassed $100 million in annualized recurring revenue, significantly exceeding initial expectations. The CEO and Co-Founder of Prenetics, Danny Yeung, expressed optimism regarding IM8’s future, highlighting the unanimous decision by the Board and management team to channel resources toward maximizing shareholder value through the brand’s ongoing growth.
Prenetics currently maintains a strong financial position, boasting over $70 million in cash and cash equivalents alongside its existing Bitcoin holdings of 510 BTC. The absence of debt further supports the company’s ability to focus its capital towards expanding IM8’s operations, innovation, brand development, and international reach.
With this renewed commitment, Prenetics aims to enhance strategic clarity and align its governance with shareholder priorities, all while navigating the promising landscape of consumer health and wellness. The company’s decision to forgo additional investments in Bitcoin underscores its dedication to fostering the growth of IM8, backed by cutting-edge scientific research and collaboration with notable partners, including David Beckham.
The IM8 brand is positioned to transform the personalized wellness market, providing consumers with a comprehensive supplement—Daily Ultimate Essentials—that combines the benefits of 16 individual supplements into a convenient and certified product.
As Prenetics fully embraces the potential of the IM8 brand, the future appears bright, with expectations for significant growth and a strengthened commitment to health and longevity for its consumers.